Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Lomecel-B improves physical function in phase IIb study in patients with aging frailty

Aug. 16, 2021

New PSMB8 inhibitors divulged by Shouyao Holdings

Aug. 11, 2021

New cyclophilin ligands described by Harvard College

Aug. 5, 2021

Beijing Kang Dini Pharmaceutical presents new IL-8 expression inhibitors

Aug. 2, 2021

Sitryx Therapeutics presents new NFE2L2 activators

July 20, 2021

Roche, Monash University describe IL-37 fusion proteins

July 14, 2021

New cannabinoid CB2 receptor agonists discovered at Corbus Pharmaceuticals

July 2, 2021

Period piece: endometrial organoids from menstrual blood

June 21, 2021

Chinese investigators describe new JAK inhibitors

June 18, 2021

Corbus Pharmaceuticals divulges cannabinoid CB2 receptor agonists

May 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...